BACKGROUND: Danon disease is due to primary deficiency of lysosome-associated membrane protein-2. OBJECTIVE: To define the clinicopathologic features of Danon disease. METHODS: The features of 20 affected men and 18 affected women in 13 families with genetically confirmed Danon disease were reviewed. RESULTS: All patients had cardiomyopathy, 18 of 20 male patients (90%) and 6 of 18 female patients (33%) had skeletal myopathy, and 14 of 20 male patients (70%) and one of 18 female patients (6%) had mental retardation. Men were affected before age 20 years whereas most affected women developed cardiomyopathy in adulthood. Muscle histology revealed basophilic vacuoles that contain acid phosphatase-positive material within membranes that lack lysosome-associated membrane protein-2. Heart transplantation is the most effective treatment for the otherwise lethal cardiomyopathy. CONCLUSIONS: Danon disease is an X-linked dominant multisystem disorder affecting predominantly cardiac and skeletal muscles.
BACKGROUND: Danon disease is due to primary deficiency of lysosome-associated membrane protein-2. OBJECTIVE: To define the clinicopathologic features of Danon disease. METHODS: The features of 20 affected men and 18 affected women in 13 families with genetically confirmed Danon disease were reviewed. RESULTS: All patients had cardiomyopathy, 18 of 20 male patients (90%) and 6 of 18 female patients (33%) had skeletal myopathy, and 14 of 20 male patients (70%) and one of 18 female patients (6%) had mental retardation. Men were affected before age 20 years whereas most affected women developed cardiomyopathy in adulthood. Muscle histology revealed basophilic vacuoles that contain acid phosphatase-positive material within membranes that lack lysosome-associated membrane protein-2. Heart transplantation is the most effective treatment for the otherwise lethal cardiomyopathy. CONCLUSIONS: Danon disease is an X-linked dominant multisystem disorder affecting predominantly cardiac and skeletal muscles.
Authors: Jiwon Kim; Parag Parikh; Mohammad Mahboob; James A Arrighi; Michael K Atalay; Ethan J Rowin; Martin S Maron Journal: Tex Heart Inst J Date: 2014-06-01
Authors: Dan D Le; Paulino Alvarez; Roberto Barrios; Michael Arriaga; Mariyam Cherry; Dipan Shah; C Huie Lin Journal: Methodist Debakey Cardiovasc J Date: 2016 Oct-Dec
Authors: P Charron; E Villard; P Sébillon; P Laforêt; T Maisonobe; L Duboscq-Bidot; N Romero; V Drouin-Garraud; T Frébourg; P Richard; B Eymard; M Komajda Journal: Heart Date: 2004-08 Impact factor: 5.994
Authors: Filip Majer; Ondrej Pelak; Tomas Kalina; Hana Vlaskova; Lenka Dvorakova; Tomas Honzik; Tomas Palecek; Petr Kuchynka; Martin Masek; Jiri Zeman; Milan Elleder; Jakub Sikora Journal: J Inherit Metab Dis Date: 2013-05-29 Impact factor: 4.982